Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Exercise of Options and Director Dealing

16 Jan 2020 15:18

RNS Number : 0782A
Judges Scientific PLC
16 January 2020
 

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

Exercise of Options and Director dealing

 

The Company has today issued 20,000 new ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options at a price of £14.38 under the Company's Unapproved Share Option Scheme. The new Ordinary Shares are being issued under the Company's current blocklisting.

The options were exercised by the Group Finance Director, Brad Ormsby. They were granted when he joined the Company in April 2015. He has today also sold 19,000 Ordinary Shares at £49.75 per Ordinary Share, partially to finance the cost of exercising the options, the resulting income tax and employer's National Insurance liabilities.  

Following the exercise and sale, Brad Ormsby's holding in the Company has increased by 1,000 Ordinary Shares and therefore his resulting interest in the Company has increased to 3,680 Ordinary Shares representing 0.06 per cent. of the issued Ordinary share capital. In addition, he holds remaining options of 10,000 Ordinary Shares under the Company's Unapproved Share Option Scheme.

Following the allotment of these shares, the enlarged issued Ordinary share capital will be 6,246,091 Ordinary Shares.

 

For further information please contact:

Judges Scientific

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3865 4219

judges@almapr.co.uk

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Bradley Ormsby

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Finance Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Exercise of options and subsequent sale of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1437.5p

20,000

4975.0p

19,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (two separate single transactions

e)

 

Date of the transaction

 

 

16/01/2020

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUNAVRRNUAAAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.